Cargando…
Short stature as a presenting symptom of attenuated Mucopolysaccharidosis type I: case report and clinical insights
BACKGROUND: Mucopolysaccharidosis type I (MPS I) results in significant disease burden and early treatment is important for optimal outcomes. Recognition of short stature and growth failure as symptoms of MPS I among pediatric endocrinologists may lead to earlier diagnosis and treatment. CASE PRESEN...
Autores principales: | Martins, Ana Maria, Lindstrom, Kristin, Kyosen, Sandra Obikawa, Munoz-Rojas, Maria Veronica, Thibault, Nathan, Polgreen, Lynda E. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6233567/ https://www.ncbi.nlm.nih.gov/pubmed/30419879 http://dx.doi.org/10.1186/s12902-018-0311-x |
Ejemplares similares
-
Oxidative stress assessment by glutathione peroxidase activity and
glutathione levels in response to selenium supplementation in patients with
Mucopolysaccharidosis I, II and VI
por: de Oliveira-Silva, José Araújo, et al.
Publicado: (2019) -
Alternative laronidase dose regimen for patients with mucopolysaccharidosis I: a multinational, retrospective, chart review case series
por: Horovitz, Dafne Dain Gandelman, et al.
Publicado: (2016) -
Definition and prevalence of familial short stature
por: Grigoletto, Veronica, et al.
Publicado: (2021) -
Growth in individuals with attenuated mucopolysaccharidosis type I during untreated and treated periods: Data from the MPS I registry
por: Polgreen, Lynda E., et al.
Publicado: (2022) -
Lysosomal Acid Lipase Deficiency: Report of Five Cases across the Age Spectrum
por: Curiati, Marco Antonio, et al.
Publicado: (2018)